LOREAL USA
FDA Approved Drugs

LOREAL USA

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

OTC
  • Total Records 5
  • Latest Approval Date Oct 29, 2009
  • Data Source FDA
  • First Approval Date Jul 21, 2006
Company Overview

Company

LOREAL USA

Country

U.S.A

Website

Visit Website

Email

media@us.loreal.com

Social Profiles

Company Snapshot

LOREAL USA

L'Oreal USA

U.S.A

www.loreal.com/en/usa/ media@us.loreal.com View on Map
FDA Approved Drug Records ( 5 records )
2006
05 Oct
OTC Application: 21471

Drug Name

ANTHELIOS 20

Product Number

1

Dosage Form

-

Strength

2%;2%;10%;2%

Approval Date

2006-10-05

21471 / 1

Active Ingredient

AVOBENZONE; ECAMSULE; OCTOCRYLENE; TITANIUM DIOXIDE

Application Number

21471

Product Number

1

Dosage Form

-

Strength

2%;2%;10%;2%

Approval Date

2006-10-05

Regulatory Status

OTC

2008
31 Mar
OTC Application: 22009

Drug Name

ANTHELIOS 40

Product Number

1

Dosage Form

-

Strength

2%;3%;10%;5%

Approval Date

2008-03-31

22009 / 1

Active Ingredient

AVOBENZONE; ECAMSULE; OCTOCRYLENE; TITANIUM DIOXIDE

Application Number

22009

Product Number

1

Dosage Form

-

Strength

2%;3%;10%;5%

Approval Date

2008-03-31

Regulatory Status

OTC

2009
29 Oct
OTC Application: 22009

Drug Name

ANTHELIOS 40

Product Number

2

Dosage Form

-

Strength

2%;3%;10%;5%

Approval Date

2009-10-29

22009 / 2

Active Ingredient

AVOBENZONE; ECAMSULE; OCTOCRYLENE; TITANIUM DIOXIDE

Application Number

22009

Product Number

2

Dosage Form

-

Strength

2%;3%;10%;5%

Approval Date

2009-10-29

Regulatory Status

OTC

2006
21 Jul
OTC Application: 21502

Drug Name

ANTHELIOS SX

Product Number

1

Dosage Form

-

Strength

2%;2%;10%

Approval Date

2006-07-21

21502 / 1

Active Ingredient

AVOBENZONE; ECAMSULE; OCTOCRYLENE

Application Number

21502

Product Number

1

Dosage Form

-

Strength

2%;2%;10%

Approval Date

2006-07-21

Regulatory Status

OTC

2006
02 Oct
OTC Application: 21501

Drug Name

CAPITAL SOLEIL 15

Product Number

1

Dosage Form

-

Strength

2%;3%;10%

Approval Date

2006-10-02

21501 / 1

Active Ingredient

AVOBENZONE; ECAMSULE; OCTOCRYLENE

Application Number

21501

Product Number

1

Dosage Form

-

Strength

2%;3%;10%

Approval Date

2006-10-02

Regulatory Status

OTC

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    5 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
5 total
  • OTC
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ANTHELIOS 20

Application Number

21471

Product Number

1

Active Ingredient

AVOBENZONE; ECAMSULE; OCTOCRYLENE; TITANIUM DIOXIDE

Dosage Form

-

Strength

2%;2%;10%;2%

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit